Paper20175765
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence.
Saunders D and 3 others. Aliment Pharmacol Ther, 2010. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Papers, record 20175765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175765
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Obesity | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Body Mass Index | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Risk Factors | |
| Young Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04455932 | HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation | Results |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 20636625 | Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma. | https://conductscience.org/library/papers/20636625 |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40168281 | Association of overweight/obesity and digestive system cancers: A meta-analysis and trial sequential analysis of prospective cohort studies. | PLoS One | 2025 | https://conductscience.org/library/papers/40168281 | PubMed |
| 40144468 | Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study. | Liver Cancer | 2025 | https://conductscience.org/library/papers/40144468 | PubMed |
| 39867264 | Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus. | J Hepatocell Carcinoma | 2025 | https://conductscience.org/library/papers/39867264 | PubMed |
| 39733406 | Factors Associated with Hepatocellular Carcinoma among Patients Receiving Treatment at the National Cancer Institute, Thailand: A Case-Control Study. | Asian Pac J Cancer Prev | 2024 | https://conductscience.org/library/papers/39733406 | PubMed |
| 39474397 | Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/39474397 | PubMed |
| 38929668 | The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38929668 | PubMed |
| 37429366 | Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. | Gastroenterology | 2023 | https://conductscience.org/library/papers/37429366 | PubMed |
| 36714595 | Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36714595 | PubMed |
| 36687124 | Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/36687124 | PubMed |
| 35818404 | Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | https://conductscience.org/library/papers/35818404 | PubMed |
| 35269779 | Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269779 | PubMed |
| 35130416 | Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area. | Clin Mol Hepatol | 2022 | https://conductscience.org/library/papers/35130416 | PubMed |
| 34888493 | The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma. | J Transl Genet Genom | 2021 | https://conductscience.org/library/papers/34888493 | PubMed |
| 33513939 | Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33513939 | PubMed |
| 33349658 | Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33349658 | PubMed |
| 31988864 | Hepatocellular Carcinoma in Asia: A Challenging Situation. | Euroasian J Hepatogastroenterol | 2019 | https://conductscience.org/library/papers/31988864 | PubMed |
| 31853685 | HCC screening: assessment of an abbreviated non-contrast MRI protocol. | Eur Radiol Exp | 2019 | https://conductscience.org/library/papers/31853685 | PubMed |
| 31781900 | Transarterial chemoembolization for hepatocellular carcinoma: quality of life, tumour response, safety and survival comparing two types of drug-eluting beads. | Abdom Radiol (NY) | 2020 | https://conductscience.org/library/papers/31781900 | PubMed |
| 31244307 | Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC. | Asian Pac J Cancer Prev | 2019 | https://conductscience.org/library/papers/31244307 | PubMed |
| 30873458 | Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1. | J Clin Transl Res | 2016 | https://conductscience.org/library/papers/30873458 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20175765
GET https://conductscience.org/api/papers/v1/20175765/cited_by?page=2